At a glance
ClinicalIndex Comparison RecordN/ACompleted· 227 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Post-Authorisation Safety Study to Evaluate the Effectiveness of VIZAMYL™ Reader Training in Europe
In Brief
An observational study for Cognitive Impairment. Completed, enrolled 227 participants across 10 sites in 5 countries.
Detailed Summary
This is a study to determine the effectiveness of the VIZAMYL™ reader training programme in clinical practice in Europe
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsCognitive Impairment
CountriesAustria, Finland, Italy, Netherlands, Spain
CollaboratorsICON plc
Timeline
N/ACompletedFinished
20192020202120222023202420252026
Enrollment StartDec 2018
First PostedFeb 2021
Primary CompletionDec 2021
TodayJul 2026
First PostedFeb 26, 2021
Enrollment StartDec 11, 2018
Primary CompletionDec 7, 2021
TodayJul 2, 2026
Enrollment to primary: 3.0 yearsPosted 5.4 years ago